Owner High Point Pharmaceuticals, LLC

Inventors Sauerberg, Per; Pihera, Pavel; Polivka, Zdenek; Havranek, Miroslav; Pettersson, Ingrid; Mogensen, John Patrick

Agent Shelston IP

Pub. Number AU-A-2011253593

Parent 2006327003

Filing date 22 November 2011

Wipo publication date 15 December 2011

C07C 59/68 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07C 323/16 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/16 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/54 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom